PREVALENCE AND ASSOCIATED FACTORS OF ENDOSCOPIC GASTRIC ATROPHY AMONG PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS AT PHENIKAA UNIVERSITY HOSPITAL

Văn Huy Phạm1,2, , Thị Bạch Tuyết Nguyễn1, Thị Liên Trần1,2
1 Đại học Phenikaa
2 Bệnh viện Đại học Phenikaa

Main Article Content

Abstract

Objective: To determine the prevalence of endoscopically diagnosed gastric mucosal atrophy and analyze factors associated with gastric mucosal atrophy in patients presenting with upper gastrointestinal symptoms.


Subjects and methods: A descriptive cross-sectional study was conducted among patients with upper gastrointestinal symptoms who attended Phenikaa University Hospital and underwent upper gastrointestinal endoscopy between 01/2025 and 01/2026.


Results: Among 357 patients with upper gastrointestinal symptoms who underwent endoscopy, 73 were diagnosed with gastric mucosal atrophy, corresponding to a prevalence of 20.4%. The mean age of patients with gastric mucosal atrophy was 57.58 ± 12.24 years. The prevalence of gastric mucosal atrophy increased significantly with age, p < 0.001. The prevalence of Helicobacter pylori infection was significantly higher in patients with gastric mucosal atrophy than in those without atrophy, at 57.5% versus 40.5%, respectively (p = 0.009). The prevalence of gastric mucosal atrophy among patients aged 60 years or older was 40.2%, markedly higher than the 13.9% observed in patients younger than 60 years (p < 0.001). Intestinal metaplasia was detected in 23.3% of patients with gastric mucosal atrophy and in 0.7% of those without atrophy (p < 0.001). Univariate analysis showed that H. pylori infection, age ≥60 years, and intestinal metaplasia were significantly associated with gastric mucosal atrophy, with odds ratios of 1.991, 4.529, and 42.804, respectively.


Conclusion: Endoscopically diagnosed gastric mucosal atrophy was present in approximately one-fifth of patients with upper gastrointestinal symptoms. Age ≥60 years, H. pylori infection, and intestinal metaplasia were significantly associated with gastric mucosal atrophy, with intestinal metaplasia showing the strongest association. These findings highlight the importance of careful assessment for gastric mucosal atrophy in older patients, identification and eradication of H. pylori infection, and detection of premalignant lesions such as intestinal metaplasia during endoscopy and subsequent follow-up.

Article Details

References

1. Xiao S, Fan Y, Yin Z, Zhou L. Endoscopic grading of gastric atrophy on risk assessment of gastric neoplasia: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36(1):55-63. doi:10.1111/jgh.15177
2. Dinis-Ribeiro M, Libânio D, Uchima H, et al. Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025. Endoscopy. 2025;57(5):504-554. doi:10.1055/a-2529-5025
3. Hwang YJ, Kim N, Kim SE, et al. Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials. Korean J Helicobacter Up Gastrointest Res. 2018;18(4):247-257.
4. Du Y, Bai Y, Xie P, et al. Chronic gastritis in China: a national multi-center survey. BMC Gastroenterol. 2014;14(1):21. doi:10.1186/1471-230X-14-21
5. Joo YE, Park HK, Myung DS, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver. 2013;7(3):303-310. doi:10.5009/gnl.2013.7.3.303
6. Zhang Z, Zhang X. Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis. BMC Gastroenterol. 2023;23(1):37. doi:10.1186/s12876-023-02662-1
7. Leung WK, Ang TL, Shah S, et al. Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditions. Gut. 2026;75(4):685-704. doi:10.1136/gutjnl-2025-335823
8. Park JY, Lee YC, Moayyedi P, et al. Helicobacter pylori Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group Report. N Engl J Med. 2026;394(11):1131-1137. doi:10.1056/NEJMsb2515372
9. Phạm Thế Hưng, Đinh Đăng Hồng, Trần Cẩm Tú. Nghiên cứu hình ảnh teo niêm mạc dạ dày trên nội soi theo phân loại Kimura-Takemoto tại Bệnh viện Bưu Điện. Tạp chí Nghiên cứu Y học. 2025;189(4):160-168. doi:10.52852/tcncyh.v189i4.3239.